Literature DB >> 25209307

Medication adherence and resistant hypertension.

D J Hyman1, V Pavlik1.   

Abstract

Non-adherence has been a major concern in the treatment of hypertension and is particularly important in understanding and intervening in patients who appear to have resistant hypertension. Relatively few studies have examined the role of non-adherence in resistant hypertension. This review will address issues related to measurement of adherence, adherence interventions and rates of non-adherence in general hypertensive populations and in patients classified as having resistant hypertension.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25209307     DOI： 10.1038/jhh.2014.73

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


  50 in total

Review 1.  The association of depression with adherence to antihypertensive medications: a systematic review.

Authors:  Chete M Eze-Nliam; Brett D Thombs; Bruno B Lima; Cheri G Smith; Roy C Ziegelstein
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

2.  Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.

Authors:  Thomas J Bramley; Philip P Gerbino; Brian S Nightengale; Feride Frech-Tamas
Journal:  J Manag Care Pharm       Date:  2006-04

3.  Racial differences in blood pressure control: potential explanatory factors.

Authors:  Hayden B Bosworth; Tara Dudley; Maren K Olsen; Corrine I Voils; Benjamin Powers; Mary K Goldstein; Eugene Z Oddone
Journal:  Am J Med       Date:  2006-01       Impact factor: 4.965

4.  Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.

Authors:  Marguerite R Irvin; Daichi Shimbo; Devin M Mann; Kristi Reynolds; Marie Krousel-Wood; Nita A Limdi; Daniel T Lackland; David A Calhoun; Suzanne Oparil; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

5.  Randomised clinical trial of strategies for improving medication compliance in primary hypertension.

Authors:  D L Sackett; R B Haynes; E S Gibson; B C Hackett; D W Taylor; R S Roberts; A L Johnson
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

6.  Resistant hypertension revisited: a comparison of two university-based cohorts.

Authors:  Jay P Garg; William J Elliott; Amy Folker; Munavvar Izhar; Henry R Black
Journal:  Am J Hypertens       Date:  2005-05       Impact factor: 2.689

7.  Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy.

Authors:  Jiri Ceral; Vilma Habrdova; Viktor Vorisek; Marcel Bima; Radek Pelouch; Miroslav Solar
Journal:  Hypertens Res       Date:  2010-09-30       Impact factor: 3.872

8.  Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators.

Authors:  Andreas Zeller; Esther Ramseier; Anne Teagtmeyer; Edouard Battegay
Journal:  Hypertens Res       Date:  2008-11       Impact factor: 3.872

9.  Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.

Authors:  Larissa Grigoryan; Valory N Pavlik; David J Hyman
Journal:  J Am Soc Hypertens       Date:  2013-07-23

Review 10.  50% adherence of patients suffering chronic conditions--where is the evidence?

Authors:  Tim Mathes; Dawid Pieper; Sunya-Lee Antoine; Michaela Eikermann
Journal:  Ger Med Sci       Date:  2012-11-13
View more
  20 in total

1.  Improving treatment satisfaction to increase adherence.

Authors:  A Chiolero; M Burnier; V Santschi
Journal:  J Hum Hypertens       Date:  2015-08-20       Impact factor: 3.012

2.  Controlling Hypertension: We Have the Tools-We Just Need to Use Them.

Authors:  David J Hyman; Valory Pavlik
Journal:  J Gen Intern Med       Date:  2017-08       Impact factor: 5.128

Review 3.  Renal Denervation: a Field in Flux.

Authors:  Luke J Laffin; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

Review 4.  Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?

Authors:  Luke J Laffin; George L Bakris
Journal:  Am J Hypertens       Date:  2017-09-01       Impact factor: 2.689

5.  Using Confocal Microscopy to Generate an Accurate Vascular Model for Use in Patient Education Animation.

Authors:  Angela Douglass; Gillian Moffat; Craig Daly
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 7.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

Review 8.  Refugee and Migrant Health Literacy Interventions in High-Income Countries: A Systematic Review.

Authors:  Samara Fox; Erik Kramer; Pooja Agrawal; Annamalai Aniyizhai
Journal:  J Immigr Minor Health       Date:  2021-02-25

9.  Treatment and adherence to antihypertensive therapy in France: the roles of socioeconomic factors and primary care medicine in the ESTEBAN survey.

Authors:  Alexandre Vallée; Clémence Grave; Amélie Gabet; Jacques Blacher; Valérie Olié
Journal:  Hypertens Res       Date:  2021-01-14       Impact factor: 3.872

10.  Trajectory of systolic blood pressure in a low-income, racial-ethnic minority cohort with diabetes and baseline uncontrolled hypertension.

Authors:  Leah L Zullig; Yuanyuan Liang; Shruthi Vale Arismendez; Aron Trevino; Hayden B Bosworth; Barbara J Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-04-01       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.